Improving Resilience and Longevity for Workers Through Exercise
Přehled studie
Postavení
Postavení
Podmínky
Podmínky
Intervence / Léčba
Intervence / Léčba
Detailní popis
Typ studie
Typ studie
Zápis (Aktuální)
Zápis
Fáze
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Ontario
-
Hamilton, Ontario, Kanada, L8S4L8
- McMaster University
-
-
Kritéria účasti
Kritéria způsobilosti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- full-time or part-time administrative employees
Exclusion Criteria:
- Any other forms of arthritis
- Osteoporosis-related fracture
- History of patellofemoral symptoms
- Active non-arthritic hip or knee disease
- Hip or knee surgery
- Use of cane or walking aid
- Unstable heart condition
- Neurological conditions
- Hip, knee or ankle injuries in past 3 months
- Physician-advised restriction to physical activity
- Any injuries that would prohibit participation in exercise
- Ipsilateral ankle conditions
- Currently receiving cancer treatment
- Currently pregnant
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Počet zbraní
Zbraně a zásahy
Skupina účastníků / ArmSkupina účastníků / Arm |
Intervence / LéčbaIntervence / Léčba |
|---|---|
|
Experimentální: Exercise
The participants in this arm will be asked to attend 3 group classes per week for 12 weeks taught by a certified exercise instructor.
Five class times will be offered per week.
These classes included a warm-up, static poses shown to decrease knee joint loading, and a cool down including flexibility exercises.
Measurements will be obtained at baseline (before intervention) and at follow-up (following intervention).
Outcomes included clinical mobility; pain; isometric leg strength; cardiovascular fitness; and resilience.
|
A biomechanical exercise program shown to decrease joint loading will be administered 3 times a week for 12 weeks.
Outcomes included mobility performance; pain; strength; cardiovascular fitness; and resilience.
|
|
Jiný: No Exercise
The participants in this arm will be asked to refrain from changing their physical activity over the 12 weeks and maintain any strategies typically used to manage knee and/or hip pain.
Since it is known that exercise is beneficial for pain management and strengthening in knee OA, participants randomized to the no exercise group will be offered the same exercise program following completion of the study.
Measurements will be obtained at baseline (before intervention) and at follow-up (following intervention).
Outcomes included clinical mobility; pain; isometric leg strength; cardiovascular fitness; and resilience.
|
A no exercise (control) group will be asked to maintain their existing activity level for 12 weeks.
Outcomes included mobility performance; pain; strength; cardiovascular fitness; and resilience.
|
Co je měření studie?
Primární výstupní opatření
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in Lower Extremity Functional Scale
Časové okno: Weeks 1 and 13
|
The Lower Extremity Function Scale (LEFS) consists of 20 items, on an adjectival scale, that assess difficulty during mobility tasks ranging from transfers to running.
Each item is scored from 0 (extreme difficulty or unable to perform activity), to 4 (no difficulty to perform activity).
The minimum possible score is 0, and the maximum possible score is 80. Scores closer to 80 represent better self-reported physical function.
It is reliable and valid in knee OA and has superior sensitivity to change compared to similar measures
|
Weeks 1 and 13
|
Sekundární výstupní opatření
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in Self-reported Knee and Hip Pain
Časové okno: Weeks 1 and 13
|
Change in self-reported knee and hip pain will be assessed with 3 valid and reliable questionnaires: the Knee injury and Osteoarthritis Outcome Score (KOOS), the Hip disability and Osteoarthritis Outcome Score (HOOS), and the Intermittent and Constant Osteoarthritis Pain (ICOAP) score.
The KOOS and HOOS pain scores represent a normalized score from 0 (extreme symptoms) to 100 (no symptoms).
KOOS and HOOS scores closer to 100 indicate fewer symptoms.
The ICOAP consists of two sub-scales: constant pain (5 items) and intermittent pain (6 items).
The score from each subscale represents a normalized score from 0 (no pain) to 100 (extreme pain).
ICOAP scores closer to 0 indicate less pain.
The items from each subscale are averaged to produce a normalized ICOAP total score, ranging from 0 (no pain) to 100 (extreme pain).
|
Weeks 1 and 13
|
|
Change in Self-reported Upper Extremity Pain
Časové okno: Weeks 1 and 13
|
The Disabilities of the Arm Shoulder and Hand is a 30-item questionnaire addressing upper extremity physical function and symptoms.
The DASH is suitable for people with any upper limb musculoskeletal disorders and can also monitor changes in severity of symptoms and functional abilities over time.
Each item is scored from 1 (no difficulty) to 5 (unable).
Total scores range from 0 to 100, with higher scores indicating more upper limb problems.
|
Weeks 1 and 13
|
|
Change in Isometric Knee Extensor and Flexor Strength
Časové okno: Weeks 1 and 13
|
The peak torque developed during knee extension and flexion during a maximum isometric contraction will be measured by use of a ergoFET hand-held dynamometer.
|
Weeks 1 and 13
|
|
Change in Grip Strength
Časové okno: Weeks 1 and 13
|
Grip strength will be assessed using a Jamar hand dynamometer.
The hand dynamometer will be set to a fixed position and all values of grip force will be expressed in kg.
|
Weeks 1 and 13
|
|
Change in Cardiovascular Fitness
Časové okno: Weeks 1 and 13
|
Cardiovascular fitness will be calculated using the Single Stage Treadmill Walking Test.
Predictions of VO2max will be made from heart rate (measured with a heart rate monitor), walking speed, age and gender.
|
Weeks 1 and 13
|
|
Change in Mobility Performance (Six-Minute Walk Test)
Časové okno: Weeks 1 and 13
|
Mobility performance will be measured using the Six-Minute Walk Test (6MWT).
For this test, participants are instructed to walk as far as possible in 6 minutes.
The distance covered in 6 minutes is recorded in metres.
This measure has produced reliable and valid data in persons with knee OA.
|
Weeks 1 and 13
|
|
Change in Mobility Performance (Stair Ascent and Descent)
Časové okno: Weeks 1 and 13
|
Mobility performance will be measured using the Stair Ascent and Descent Test.
For this test, the time taken to ascend, as well as descend nine stairs is recorded in seconds.
This measure has produced reliable and valid data in persons with knee OA.
|
Weeks 1 and 13
|
|
Change in Mobility Performance (30-second Chair Stand Test)
Časové okno: Weeks 1 and 13
|
Mobility performance will be measured using the 30-second Chair Stand Test.
This test measures the number of times participants can rise and lower from a standard height chair, without using arm rests, in a 30-second period.This measure has produced reliable and valid data in persons with knee OA.
|
Weeks 1 and 13
|
|
Change in Resilience
Časové okno: Weeks 1 and 13
|
Resilience will be measured using the Resilience Scale 25 Survey, which is a 25-item questionnaire designed to evaluate a participants ability to adapt to stress and adversity.
The test is scored out of 175 (scores ranging from 25 to 175), with higher scores indicating higher resilience.
|
Weeks 1 and 13
|
|
Change in Work Ability
Časové okno: Weeks 1 and 13
|
The Work Ability Index (WAI) is a widely-used self-report questionnaire that evaluates a worker's capacity to perform a job accounting for their physical and mental well-being in addition to the demands of their job.
The WAI consists of seven dimensions including current work ability relative to life-time best, work ability related to job demands, number of current physician-diagnosed health conditions, estimated work impairment due to the conditions, sick leave over the past year, own prognosis, and mental resources.
Total scores range from 7 to 49 and can fall under one of four classifications: poor work ability that should be restored (7-27), moderate work ability that should be improved (28-36), good work ability that should be supported (37-43), and excellent work ability that should be maintained (44-49).
The WAI produces reliable data.
|
Weeks 1 and 13
|
|
Change in Depressive Symptoms
Časové okno: Weeks 1 and 13
|
Depression will be assessed with the Centre of Epidemiological Studies Depression (CES-D) Scale, a 20-item scale developed for the general population with emphasis on affect.
Elements of affect include mood, guilt, worthlessness, helplessness, appetite, and sleep.
Each item is scored from 0 (rarely or none of the time), to 3 (most of the time).
The items are summed to produce a total score between 0 and 60 with a score of 16 or higher indicating depression.
|
Weeks 1 and 13
|
|
Change in Arthritis-related Self-Efficacy
Časové okno: Weeks 1 and 13
|
The Arthritis Self-Efficacy Scale (ASES) measures arthritis-specific beliefs regarding perception of performance on certain tasks to cope with the disease.
The ASES is measured using 20 questions on a 10-100 scale with respect to three main areas: pain management (5 questions), physical function (9 questions), and other symptoms (6 questions).
Each question is scored from 10 (very uncertain), to 100 (very certain), in 10-point increments.
The minimum score for each subscale is 10, and the maximum score for each subscale is 100.
The scores from each subscale are averaged to produce a normalized total score.
Scores closer to 100 indicate greater certainty that a participant can cope with a particular task as a consequence of their disease.
|
Weeks 1 and 13
|
Spolupracovníci a vyšetřovatelé
Sponzor
Sponzor
Vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Monica R Maly, PT, PhD, McMaster University
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Začátek studia
Primární dokončení (Aktuální)
Primární dokončení
Dokončení studie (Aktuální)
Dokončení studie
Termíny zápisu do studia
První předloženo
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
První zveřejněno
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Poslední zveřejněná aktualizace
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
Další identifikační čísla studie
- Workplace Exercise
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .